Use Science in Cases Alleging Pregnancy and Drug Use, Orgs and Experts Argue in Court Brief
National Advocates for Pregnant Women
www.advocatesforpregnantwomen.org
For Immediate Release:
Contact: Lynn Paltrow
January 10, 2012
50 Leading Medical, Public Health and Child Welfare Organizations and Experts File Brief Insisting on Science not Stigma in Child Welfare Decisions Involving Pregnant Women and Allegations of Drug Use
Drug War Propaganda and Junk Science No Basis for Child Neglect and Abuse Finding
TRENTON, NJ (Jan. 10, 2012): On January 10, a group of fifty medical, public health and child welfare experts and advocates filed a motion to submit an amicus (friend of the court) brief before the state’s highest judicial authority challenging a finding of neglect against a mother identified in court records as “A.L.,” and an Appellate Division decision that radically expands the scope of the state’s civil child neglect and abuse laws to apply to a pregnant woman in relation to the fetus she carries and sustains.
In this case, New Jersey Division of Youth and Family Services (DYFS) v. A.L., A.L. gave birth to a healthy baby in September of 2007. DYFS argued that positive drug screens for cocaine on A.L. and her newborn were sufficient evidence of harm or imminent harm to find that A.L. had neglected her child. A lower court and the Appellate Division agreed, not only finding neglect in this case but also declaring that a New Jersey’s neglect law could be applied to the context of pregnancy. On October 26, 2011, the New Jersey Supreme Court agreed to review the case.
In their brief, amici focus on the New Jersey Supreme Court’s commitment to the use of reliable scientific evidence in judicial decisionmaking. Amici argued that the lower courts relied on popular assumptions about drugs, pregnant women, and child welfare that lack any foundation in evidence-based, peer-reviewed research.
Lawrence S. Lustberg, Esq. of Gibbons P.C., co-counsel representing amici, explains that “the New Jersey Supreme Court has been a national leader in recognizing that when cases raise scientific, medical, or other technical issues, the evaluation of these issues must be informed by existing scientific knowledge, including expert testimony. This case should be no exception.”
Amici also note that DYFS presented no evidence that the child had suffered any actual injury at birth or at any time after birth, and presented no witnesses with expertise regarding the effects of prenatal exposure to cocaine, what drug test results mean, or the association between a pregnant woman’s drug use and a likelihood of abuse or neglect of a child once born. Nor did DYFS present, or the lower courts consider, the vast body of medical and social science research on these questions.
“Pregnant women and children who are caught up in the child welfare system and who are disproportionately low-income and of color, no less than other people, deserve decisions that are grounded in evidence-based research,” said Emma S. Ketteringham, co-counsel in the case and Director of Legal Advocacy for amici National Advocates for Pregnant Women. Ms. Ketteringham added, “Pregnant women and families should not be deprived of their fundamental rights -- including the right to family relationships -- based on junk science, or no science at all.”
Expert amici explained to the court that medical research makes clear that numerous substances, conditions, and circumstances raise similar or greater risks to fetuses as prenatal exposure to cocaine. While amici were careful to note that they were not suggesting that prenatal exposure to criminalized drugs is benign, they emphasized that current scientific evidence simply does not support judicially re-writing state law to allow for a per se finding of abuse or neglect based solely on evidence of a woman’s use of cocaine or other criminalized drugs during pregnancy.
Amici also noted that there is no research to support the idea that a positive drug test demonstrates harm, risk of harm, or a likelihood of neglect or abuse. They emphasized, however, that there is research finding that threats of punishment, including of loss of child custody, deter pregnant women from care, undermining rather than advancing maternal, fetal and child health.
Wendy Chavkin, MD, MPH, a physician and researcher who has written extensively about the issue of drug use and pregnancy, observed: “These issues have become caught up in other political battles. It is critical that state agencies, like DYFS, and the court base their decision on scientific evidence, not on misinformation and stereotype.”
Ms. A. L. is represented by Clara Licata of the New Jersey Office of Parental Representation.
The amici organizations include: American College of Obstetricians and Gynecologists, Addiction Science Research and Education Center, American Academy of Addiction Psychiatry, American Society of Addiction Medicine, International Centre on Science in Drug Policy, International Doctors for Healthy Drug Policies, National Perinatal Association, National Coalition for Child Protection Reform, Child Welfare Organizing Project, Health Right International (Former Doctors of the World-USA), National Women’s Health Network.
A copy of amicus brief accompanying the motion to submit, including and a complete list of organizations and experts is available at:
http://advocatesforpregnantwomen.org/briefs/NJ%20DYFS%20v.%20AL%20Brief%20of%20Amici%20Curiae.pdf
Additional Resources:
Don't Judge Pregnant Women Based on Junk Science
These Are Your Rights on Drugs (Opinion)
Marijuana and Racial Inequality: A "Cannabis Day" Look at How Marijuana Arrests Discriminate Against Young Black People
Is DARE Program Worth It?
Why It's Obvious We Are Losing the War on Drugs
More Black Men in Prison Today Than Enslaved in 1850, Drug Laws the Reason
First Federal Agency to Acknowledge Medical Marijuana Removes Anti-Tumor Information from Database
U.S. Led Drug Prohibition Wars Have Failed, Expert Tells Panama Conference
New Directions New Jersey: A Public Safety and Health Approach to Drug Policy
The New Directions New Jersey conference will examine the decades-old ramifications of President Nixon’s declaration of the “war on drugs” in urban communities like Newark.
Drug policy experts from across the country and around the globe will discuss topics including: reducing crime and incarceration, effectively addressing addiction, treating drug use as a health issue, communities of color and the war on drugs, and drug policy lessons and models from abroad.
When asked about the war on drugs on the campaign trail, President Barack Obama said, “I believe in shifting the paradigm, shifting the model, so that we focus more on a public health approach [to drugs].” Polls show the American people agree. President Obama’s drug czar, Gil Kerlikowske, told the Wall Street Journal last year that he doesn’t like the term “war on drugs” because “[w]e’re not at war with people in this country.” Yet for the tens of millions of Americans who have been arrested and incarcerated for a drug offense, U.S. drug policy is a war on them—and their families. What exactly is a public health approach to drugs? What might truly ending the war on drugs look like? This conference will serve as a model for those looking for new directions and strategies for ending the war on drugs.
“We see the impact of the ‘drug war’ first hand, where so many people are incarcerated for being economically disadvantaged by the disappearance of work,” says Bethany Baptist Church pastor, Reverend William Howard. “Afterwards, they are virtually permanently barred from the legal workforce for the rest of their lives. We must take our stand against the destructive scourge of drug abuse and trafficking by developing new, sensible strategies that solve more problems than they create.”
The conference will be guided by four principles:
- The war on drugs has failed and it is time for a new approach to drug policy.
- Effective drug policy balances prevention, harm reduction, treatment and public safety.
- Alcohol and other drug use is fundamentally a health issue and must be addressed as such.
- Drug policies must be based on science, compassion, health and human rights.
Panel members and conference speakers include:
· Rev. Dr. M. William Howard, Jr., pastor, Bethany Baptist Church
· Ethan Nadelmann,executive director, Drug Policy Alliance
· Paula T. Dow, New Jersey Attorney General
· Garry F. McCarthy, police director, City of Newark
· Michelle Alexander, Esq., associate professor, Ohio State University’s Moritz College of Law and the Kirwan Institute for the Study of Race and Ethnicity; Author, The New Jim Crow: Mass Incarceration in the Age of Colorblindness
· Beny Primm, MD, executive director, Addiction, Research and Treatment Corporation, Brooklyn, New York
· Todd Clear, dean, School of Criminal Justice, Rutgers University
· Donald MacPherson, former drug policy coordinator, City of Vancouver
· Alex Stevens, professor of Criminal Justice, School of Social Policy, Sociology and Social Research, University of Kent, Chatham, UK
· Stephanie Bush-Baskette, Esq., Author and Director of the Joseph C. Cornwall Center for Metropolitan Studies at Rutgers University
· Deborah Peterson Small, Founder and Executive Director, Break the Chains: Communities of Color & the War on Drugs
For a full list of panel members, go to: http://www.drugpolicy.org/docUploads/DPA_New_Directions_NJ_final_prog_REFERENCE.pdf
Please RSVP to: bgalarza@bethany-newark.org

